Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  ACS Medicinal Chemistry Letters

• Publication date

  2018-02-21

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/acsmedchemlett.7b00512PMID 29541367PMCID PMC5846043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Discovery and characterization of highly potent and selective allosteric USP7 inhibitors.

  2018cited by this paper
• Ubiquitin System

  2018cited by this paper
• Molecular basis of USP7 inhibition by selective small-molecule inhibitors

  2017cited by this paper
• Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7.

  2017cited by this paper
• Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology Therapies.

  2017cited by this paper
• USP7 small-molecule inhibitors interfere with ubiquitin binding

  2017cited by this paper
• Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis.

  2016cited by this paper
• HAUSP deubiquitinated and stabilizes N-Myc in neuroblastoma

  2016cited by this paper
• Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases

  2016cited by this paper
• K63-polyubiquitinated HAUSP deubiquitinates HIF-1α and dictates H3K56 acetylation promoting hypoxia-induced tumour progression

  2016cited by this paper
• Recent Advances in the Discovery of Deubiquitinating Enzyme Inhibitors

  2016cited by this paper
• Deubiquitination of Ci/Gli by Usp7/HAUSP Regulates Hedgehog Signaling.

  2015cited by this paper
• Emerging potential of therapeutic targeting of ubiquitin-specific proteases in the treatment of cancer.

  2014cited by this paper
• The ubiquitin code.

  2012cited by this paper
• The Multifaceted Roles of USP7: New Therapeutic Opportunities

  2011cited by this paper
• Ubiquitin: same molecule, different degradation pathways.

  2010cited by this paper
• Breaking the chains: structure and function of the deubiquitinases

  2009cited by this paper
• The deubiquitinylation and localization of PTEN are regulated by a HAUSP–PML network

  2008cited by this paper
• Ubiquitin and ubiquitin-like proteins in cancer pathogenesis

  2006cited by this paper
• FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP

  2006cited by this paper
• Tumour suppression: Disruption of HAUSP gene stabilizes p53

  2004cited by this paper
• A phase 2 study of bortezomib in relapsed, refractory myeloma.

  2003cited by this paper
• The ubiquitin system.

  1998cited by this paper

• Computational modeling of ubiquitin specific protease 7 (USP7) complexes with N-benzylpiperidinol derivatives incorporating binding site flexibility.

  2026cites this paper
• EDA photochemistry using continuous flow

  2025cites this paper
• Design, Synthesis, and Molecular Evaluation of SNAr‐Reactive N‐(6‐Fluoro‐3‐Nitropyridin‐2‐yl)Isoquinolin‐3‐Amines as Covalent USP7 Inhibitors Reveals an Unconventional Binding Mode

  2025cites this paper
• Practical Synthesis of 3-Substituted Pyrimidin-4-ones and 4(3H)-Quinazolinones from Nitriles: Mechanistic Insights, Scope, and Scale-Up

  2025cites this paper
• Therapeutic targeting of ubiquitin-specific protease 7 (USP7): Mechanistic insights, dysregulation, and advances in drug discovery.

  2025cites this paper
• Discovery of indane and naphthalene derivatives as USP7 inhibitors.

  2025cites this paper
• Beyond Docking: A Multitier Computational Pipeline for USP7 Inhibitor Optimization

  2025cites this paper
• Rational Computational Workflow for Structure-Guided Discovery of a Novel USP7 Inhibitor

  2025cites this paper
• Ubiquitin-Specific Protease 7 (USP7) as a Promising Therapeutic Target for Drug Discovery: From Mechanisms to Therapies.

  2025cites this paper
• Targeting Ubiquitin-Specific Protease 7 (USP7): A Pharmacophore-Guided Drug Repurposing and Physics-Based Molecular Simulation Study

  2025cites this paper
• Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future Prospects

  2025cites this paper
• Discovery and characterization of potent macrocycle inhibitors of ubiquitin-specific protease-7.

  2025cites this paper
• DIALKYL ISOMERS OF BENZENESULFONAMIDPHENYLPYRIMIDINE-4(1H)-ONE: SYNTHESIS, STRUCTURE AND PHARMACOLOGICAL STUDIES

  2024cites this paper
• Structure-Guided Discovery of Selective USP7 Inhibitors with In Vivo Activity.

  2024cites this paper
• Discovery of pyrrolo[2,3-d]pyrimidin-4-one derivative YCH3124 as a potent USP7 inhibitor for cancer therapy.

  2024cites this paper
• Ubiquitin-specific protease 7 inhibitors reveal a differentiated mechanism of p53-driven anti-cancer activity.

  2024cites this paper
• USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGF

  2024cites this paper
• Backbone 1H, 13C and 15N resonance assignment of the ubiquitin specific protease 7 catalytic domain (residues 208–554) in complex with a small molecule ligand

  2024influential citation
• A comprehensive review: Protein homeostasis and an emerging therapeutic target.

  2024cites this paper
• Recent Progress of Ubiquitin-Specific-Processing Protease 7 Inhibitors

  2023cites this paper
• Expanding Heteroaromatic and 2-Aminosugar Chemical Space Accessible from the Biopolymer Chitin

  2023cites this paper
• Design, synthesis and antitumor activity evaluation of pyrimidine derivatives containing 4-hydroxypiperidine group

  2023cites this paper
• Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21

  2023cites this paper
• Discovery of Orally Bioavailable N-Benzylpiperidinol Derivatives as Potent and Selective USP7 Inhibitors with In Vivo Antitumor Immunity Activity against Colon Cancer.

  2022cites this paper
• Recent advances in the pharmacological targeting of ubiquitin-regulating enzymes in cancer.

  2022cites this paper
• A patent review of ubiquitin-specific protease 7 (USP7) inhibitors (2014-present)

  2022cites this paper
• Backbone and ILV side-chain NMR resonance assignments of the catalytic domain of human deubiquitinating enzyme USP7

  2022cites this paper
• On the Study of Deubiquitinases: Using the Right Tools for the Job

  2022cites this paper
• Discovery of a Potent and Selective Degrader for USP7.

  2022cites this paper
• Characterizing (un)binding mechanism of USP7 inhibitors to unravel the cause of enhanced binding potencies at allosteric checkpoint

  2022cites this paper
• Highlights in USP7 inhibitors for cancer treatment

  2022cites this paper
• Design, synthesis and biological evaluation of 2-aminopyridine derivatives as USP7 inhibitors.

  2022cites this paper
• Design, synthesis, biological evaluation and structure-activity relationship study of quinazolin-4(3H)-one derivatives as novel USP7 inhibitors.

  2021cites this paper
• Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors

  2021cites this paper
• Small molecules as tools for functional assessment of deubiquitinating enzyme function.

  2021cites this paper
• Targeting the MYC Ubiquitination-Proteasome Degradation Pathway for Cancer Therapy

  2021cites this paper
• Deubiquitinases: From mechanisms to their inhibition by small molecules.

  2021cites this paper
• Synthesis and biological evaluation of novel thiazolo[4,5-d]pyrimidin-7(6H)-ones as topoisomerase I inhibitors

  2021cites this paper
• CuH-Catalyzed Asymmetric Reductive Amidation of α,β-Unsaturated Carboxylic Acids.

  2020cites this paper
• N-benzylpiperidinol derivatives as novel USP7 inhibitors: Structure-activity relationships and X-ray crystallographic studies.

  2020cites this paper
• Cyanopyrrolidine Inhibitors of Ubiquitin Specific Protease 7 Mediate Desulfhydration of the Active-Site Cysteine.

  2020cites this paper
• Small molecules that target the ubiquitin system

  2020cites this paper
• Binding affinity and dissociation pathway predictions for a series of USP7 inhibitors with pyrimidinone scaffold by multiple computational methods.

  2020cites this paper
• Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors.

  2020cites this paper
• Advances in Discovering Deubiquitinating Enzyme (DUB) Inhibitors.

  2020cites this paper
• Fragment-to-Lead Medicinal Chemistry Publications in 2018.

  2020cites this paper
• The emerging nature of Ubiquitin-specific protease 7 (USP7): a new target in cancer therapy.

  2020cites this paper
• An Integrated in silico Approach and in vitro Study for the Discovery of Small‐Molecule USP7 Inhibitors as Potential Cancer Therapies

  2020cites this paper
• Small-Molecule Activity-Based Probe for Monitoring Ubiquitin C-Terminal Hydrolase L1 (UCHL1) Activity in Live Cells and Zebrafish Embryos

  2020cites this paper
• Novel, Selective Inhibitors of USP7 Uncover Multiple Mechanisms of Antitumor Activity In Vitro and In Vivo

  2020cites this paper
• USP7 Is a Master Regulator of Genome Stability

  2020cites this paper
• The ruthenium-catalyzed C-H functionalization of enamides with isocyanates: easy entry to pyrimidin-4-ones.

  2019cites this paper
• USP7: Structure, substrate specificity, and inhibition.

  2019cites this paper
• Emerging drug development technologies targeting ubiquitination for cancer therapeutics

  2019cites this paper
• From Discovery to Bedside: Targeting the Ubiquitin System.

  2019cites this paper
• Diarylcarbonates are a new class of deubiquitinating enzyme inhibitor.

  2019cites this paper
• A Small-Molecule Activity-Based Probe for Monitoring Ubiquitin C-terminal Hydrolase L1 (UCHL1) Activity in Live Cells and Zebrafish Embryos

  2019cites this paper
• The mechanism of Parkin activation by PINK1 phosphorylation

  2019cites this paper
• Structurally-defined deubiquitinase inhibitors provide opportunities to investigate disease mechanisms.

  2019cites this paper
• USP7 inhibits Wnt/β-catenin signaling through promoting stabilization of Axin

  2019cites this paper
• Molecular dynamics simulation reveals the possible druggable hot-spots of USP7

  2018cites this paper